AR and neoplasm: Using this approach, we showed that inhibition of oxidative phosphorylation significantly reduced tumor viability and caused apoptosis in two independent AR-positive LuCaP models (Figure 5), suggesting mitochondrial metabolism as a therapeutic vulnerability in AR-positive CRPC.